PharmaBoardroom

Professor Richard Barker, founder of New Medicine Partners reflects on China's very different approach to the biopharma industry. Napoleon…

Key statistics on the workforce, revenue, investment levels, R&D spending and consumption in the French pharmaceutical industry today.…

Ignacio Vega and Carlos Ibares Sanz of Spanish medtech Cardiva, explain the group’s origins as a distributor, the growing importance of…

Santiago Ruiz, entering his fourth year leading B. Braun’s Portuguese affiliate in Lisbon, highlights the innovation present in Portugal, B. Braun's…

Mourad Belkheyar, acting director general of Varian Healthcare Algeria lifts the lid on the progress Algeria has made in its quest to bring the most…

Benjamin Chan of MediConcepts – a Hong Kong-based medtech CDMO – outlines the potential impact of the Greater Bay Area Initiative on Hong Kong…

Didier Geneau provides a fascinating insight into the French biotech scene; its strengths but also weaknesses. France has an incredible track-record…

Andy A. Liu, CEO of CW Data Technologies, a joint venture between WuXi AppTec and China Electronics Data Corporation at the intersection of Big Data…

Ersin Erfa, general manager of Centurion, which recently set up one of Turkey’s largest biotechnology plants in Ankara, dives into the world of…

Spanish stakeholders have been trailblazing the concept of the “liquid hospital”, which envisions the virtual and physical expansion of healthcare…

Aditya Bhattacharji manages Eurasia Group's healthcare analysis. He calls for healthcare to be given a new prescription. But, will the private…

This week the NHS becomes the first in the world to routinely offer access to breakthrough genomic medicine. Today (1st October 2018) marks a huge…